Join
Live feed
·
INSIDERFilingvia Quantisnow
Jade Biosciences Inc. logo

Chief Financial Officer Dahms Bradford D. was granted 37,813 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
JBIO· Jade Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JBIO (Jade Biosciences Inc.) and more on Quantisnow.